Clinical trial
Transition From Parenteral Prostanoids to Inhaled Treprostinil
NCT01268553 is registered in ClinicalTrials.gov with Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transition From Parenteral Prostanoids to Inhaled Treprostinil
- Lead sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- October 5, 2016
- Enrollment
- 6 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.